Octreotide in the United States
13 medicine records from 8 holders carry this name in the official sources. Collected on November 19, 2026.
Medicines
| Name | Holder | Code |
|---|---|---|
| Mycapssa CAPSULE, DELAYED RELEASE | Chiesi USA, Inc. |
Product NDC
10122-550Package NDC
10122-550-28
|
| Mycapssa CAPSULE, DELAYED RELEASE | Amryt Pharmaceuticals Designated Activity Company |
Product NDC
69880-120Package NDC
69880-120-28
|
| Octreotide POWDER | BCN PEPTIDES SA |
Product NDC
35207-0002Package NDC
35207-0002-5
|
| Octreotide POWDER | Ambiopharm, Inc. |
Product NDC
41524-0007Package NDC
41524-0007-1
|
| Octreotide POWDER | Bachem Americas, Inc. |
Product NDC
52416-109Package NDC
52416-109-01
|
| Octreotide POWDER | USV Private Limited |
Product NDC
62147-0206Package NDC
62147-0206-0
|
| Octreotide INJECTION, SOLUTION | Fresenius Kabi USA, LLC |
Product NDC
63323-376Package NDC
63323-376-01
|
| Octreotide INJECTION, SOLUTION | Fresenius Kabi USA, LLC |
Product NDC
63323-376Package NDC
63323-376-04
|
| Octreotide INJECTION, SOLUTION | Fresenius Kabi USA, LLC |
Product NDC
63323-377Package NDC
63323-377-01
|
| Octreotide INJECTION, SOLUTION | Fresenius Kabi USA, LLC |
Product NDC
63323-377Package NDC
63323-377-04
|
| Octreotide INJECTION, SOLUTION | Fresenius Kabi USA, LLC |
Product NDC
63323-378Package NDC
63323-378-05
|
| Octreotide INJECTION, SOLUTION | Fresenius Kabi USA, LLC |
Product NDC
63323-379Package NDC
63323-379-05
|
| Octreotide POWDER | LSNE, Inc. |
Product NDC
73301-004Package NDC
73301-004-01
|
Need this list in your own system?
Every record on this page is available through the API, with its source, licence and retrieval date.